Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone and Growth Hormone for Bone Structure in Hypopituitarism
NCT00080483Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Mar 2004
- Primary completion
- Sep 2010
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by University of Pennsylvania. Primary endpoint: MicroMRI-derived Structural Bone Volume Fraction of the Distal Tibia at 2 years. Started Mar 2004; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00080483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080483.